Literature DB >> 1975879

High-dose intravenous immunoglobulin for multiple sclerosis.

J Yan, J R Richert, M D Sirdofsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1975879     DOI： 10.1016/0140-6736(90)92188-n

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis.

Authors:  C Nos; M Comabella; M Tintoré; J Rio; A Codina; X Montalban; A Rovira
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

Review 2.  Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.

Authors:  B G van Engelen; D J Miller; K D Pavelko; O R Hommes; M Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

3.  Neuromyelitis optica.

Authors:  Dean M Wingerchuk; Brian G Weinshenker
Journal:  Curr Treat Options Neurol       Date:  2008-01       Impact factor: 3.972

4.  Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE).

Authors:  Diana Straubel; Anja Thielitz; Annegret Reinhold; Kurt Grüngreiff; Dirk Reinhold
Journal:  J Immunol Res       Date:  2018-09-26       Impact factor: 4.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.